MeSH D012893 - sleep wake disorders
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Allergan | Armodafinil | Armodafinil | 2012-08-29 | |||
| Aurobindo Pharma | Armodafinil | Armodafinil | 2018-03-06 | |||
| Cephalon | Armodafinil | Nuvigil | 2023-11-29 | 2007-06-15 | $99.544 M | Q2/10-Q2/11 |
| CorePharma | Armodafinil | Armodafinil | 2019-03-25 | |||
| Lupin Research | Armodafinil | Armodafinil | 2016-11-28 | |||
| Mylan | Armodafinil | Armodafinil | 2012-06-01 | |||
| NATCO Pharma | Armodafinil | Armodafinil | 2016-11-28 |
Clinical Trials
Historical Success Rate
Phase 1
33%2/6
Phase 2
50%7/14
Phase 3
27%4/15
Approved: 1Overall Success rate: 4%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use